Hancock Mark sold $1.1M of PACS
Hancock Mark sold 25,304 shares of PACS Group, Inc. (PACS) at an average of $45.07 ($45.06–$45.07, $1.14M total) across 2 trades over 2026-07-08 to 2026-07-09 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides a concrete datapoint on insider selling size, timing, and average price, but does not include new company fundamentals.
Market read
For PACS, this is a small-to-moderate insider-sale event (about $1.14M) with limited interpretive weight due to 10b5-1 scheduling.
What to watch
Traders may over-weight insider sales; the key incremental signal would be whether multiple insiders sell concurrently or whether the company later reports material operational changes.
Background
The article is an SEC Form 4 insider transaction disclosure for PACS Group, Inc.
Ticker impact
Director and 10% owner Hancock Mark sold 25,304 PACS shares in open-market trades for about $1.14M under a 10b5-1 plan.
Likely minimal price impact; any effect is short-lived unless follow-on selling or plan changes emerge.
The filing is a Form 4 insider transaction, but it explicitly references a pre-arranged Rule 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.
Market effects
No sector-level implications; this is company-specific insider activity.
None indicated.
None indicated.
Counterpoint
Because the sale is under a pre-arranged 10b5-1 plan, it may reflect scheduled diversification rather than negative fundamentals.
Key entities
- issuerPACS Group, Inc.
Subject of the Form 4 insider sale by a director and 10% owner.
- insiderHancock Mark
Director and 10% owner who sold 25,304 shares under a Rule 10b5-1 plan.
